1. Home
  2. MIRM vs COLD Comparison

MIRM vs COLD Comparison

Compare MIRM & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$100.65

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Logo Americold Realty Trust Inc.

COLD

Americold Realty Trust Inc.

HOLD

Current Price

$12.52

Market Cap

3.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
COLD
Founded
2018
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.6B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
MIRM
COLD
Price
$100.65
$12.52
Analyst Decision
Strong Buy
Hold
Analyst Count
11
13
Target Price
$102.64
$14.85
AVG Volume (30 Days)
733.0K
4.4M
Earning Date
02-26-2026
02-19-2026
Dividend Yield
N/A
7.33%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$471,794,000.00
$2,607,407,000.00
Revenue This Year
$55.91
N/A
Revenue Next Year
$23.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
53.66
N/A
52 Week Low
$36.88
$10.10
52 Week High
$105.74
$23.52

Technical Indicators

Market Signals
Indicator
MIRM
COLD
Relative Strength Index (RSI) 64.68 46.29
Support Level $97.49 $12.51
Resistance Level $105.74 $12.98
Average True Range (ATR) 3.71 0.41
MACD -0.79 -0.04
Stochastic Oscillator 62.01 26.02

Price Performance

Historical Comparison
MIRM
COLD

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

Share on Social Networks: